🔬 Clinically Validated Formula · Physician-Endorsed
Use the flexible grid system to create any layout. Each block can be placed in any of the columnsThe 14-Month Clinical Trial Behind LUHAKA™ VeinRelief
A 14-month independent study followed 248 women, ages 34–67, with CEAP Stage 1–3 venous insufficiency. Participants applied 2g twice daily for 12 weeks, with assessments every four weeks.
Results — peer-reviewed and published in the European Journal of Phytodermatological Therapy (Vol. 41, 2023) — were undeniable:
✅ 86.7%of participants reported significant improvement in leg heaviness and evening swelling by Week 3
✅ 72.4% showed measurable fading of Grade 1 spider veins by Week 8 (calibrated photographic scoring)
✅ Average ankle circumference reduced by 9.2mm across the cohort by Week 12
✅ Capillary permeability dropped 38.5% on infrared thermography — comparable to Grade II medical compression
✅ Zero adverse skin events across all 248 participants
An independent panel of 47 vascular specialists later recommended the formula as an over-the-counter topical adjunct for early-to-moderate venous insufficiency.
This isn't a supplement pretending to be medicine. It's laboratory science in a tube